Wan-chun Wu

First-line LVDP (l-asparaginase, etoposide, dexamethasone, and cisplatin) regimen combined with radiotherapy is effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type

Xiangshan Chen, L. Zou, Wanchun Wu, 2022, Annals of Hematology.

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma

Wenwen Wei, L. Zou, Wanchun Wu, 2022, Frontiers in Pharmacology.

18F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma

R. Tian, Sha Zhao, Wanchun Wu, 2022, Frontiers in Oncology.

The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma

Na Li, M. Jiang, Wanchun Wu, 2022, Annals of Hematology.

A neutrophil/lymphocyte Ratio as a Significant Predictor for Patients with low-risk and early-stage Extranodal NK-T-cell Lymphoma

Xiangshan Chen, L. Zou, Wanchun Wu, 2022, Indian Journal of Hematology and Blood Transfusion.

Evaluation of different staging systems and prognostic analysis of nasal-type extranodal NK/T-cell lymphoma based on consistent LVDP chemotherapy regimen

Na Li, Caigang Xu, L. Zou, 2022, Translational oncology.

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy

Yi Wei, L. Zou, Wanchun Wu, 2021, Frontiers in Oncology.